CLINICAL_TRIALS
trial_result
· 2010-09-09
Clinical Trial Update: A Study for Patients With Multiple Sclerosis [Phase 2, Phase 3]
Summary
A Phase 2/3 clinical trial for secondary progressive multiple sclerosis sponsored by Eli Lilly has been terminated.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Eli Lilly and Company | Conditions: Secondary Progressive Multiple Sclerosis | Phase 2, Phase 3 | Status: TERMINATED